Kiora Pharmaceuticals Inc (KPRX) — Strategic Asset Allocation Index
Kiora Pharmaceuticals Inc (KPRX) has a Strategic Asset Allocation Index of 0.7% as of June 2023. Strategic assets (PP&E of $95.10K plus long-term investments of $-) total $95.10K, measured against net assets of $13.64 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check KPRX asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Kiora Pharmaceuticals Inc Strategic Asset Allocation Index (2018–2021)
This chart shows how Kiora Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2018 to 2021. As of June 2023, the index stands at 0.7%, representing strategic assets of $95.10K against net assets of $13.64 Million USD. See financial agility of Kiora Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Kiora Pharmaceuticals Inc (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Kiora Pharmaceuticals Inc from 2018 to 2021, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see KPRX company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 1.9% | $283.41K | $283.41K | $- | $14.58 Million | ▲ +1.6 pp |
| 2020 | 0.3% | $30.57K | $30.57K | $- | $9.73 Million | ▲ +0.1 pp |
| 2019 | 0.3% | $16.85K | $16.85K | $- | $6.62 Million | ▼ -0.2 pp |
| 2018 | 0.5% | $43.52K | $43.52K | $- | $8.94 Million | — |